Podcasts about Grand rounds

Send a textIt's the trinity of power this week. You guessed it, Beaveman, Swan, and JD bring the idiocy and the fun this week. Swan starts us off with, "This Weeks POS," as the trial of extended family/family annihilator Paul Caneiro comes to an end. He definitely qualifies as a POS. Hope he gets fitted with a sundress. She then transitions to a story about a local Grand Rapids, Michigan man who also annihilated his family. WTF, another POS. The Dark Lord of Browntown introduces some interesting theories about time that completely fries the Beaveman's brain. Is it plausible? That's for you to contemplate. The Beaveman brings it on ,"Not so Grand Rounds," with a discussion about Nipah virus. Gotta love the fruit bat, just don't love it that way you weirdo. And of course, the Swan ends the show with, "Dumb Jokes with the Swan." Is she actually getting better? You gotta give her credit, she is telling jokes to Beaveman and JD who just have to make idiot comments the entire time. Thank you to all of our listeners throughout the world! We love you! We hope we help you forget about the day-to-day crap. https://www.slaptailnation.com/Support the show

Event Objectives:Understand the scope and prevalence of neurodevelopmental impairments in children with CHD.Identify risks for neurodevelopmental impairments.Review evidence based screening recommendations.Claim CME Credit Here!

As Boston IVF becomes part of a much larger organization, a natural question emerges: Does a legacy brand get diluted, or does its history shape what comes next?In this episode, Dr. Alan Penzias reflects on Boston IVF's deep roots and how that heritage continues to influence the organization's future within the RMA network.The conversation covers:Boston IVF's founding history and the leaders who shaped itWhether scale threatens (or strengthens)  institutional cultureThe “buy-versus-build” debate playing out across fertility networksDr. Penzias's perspective on AI and evolving clinical infrastructureHow Boston IVF's tradition of Grand Rounds has scaled across the networkServing patients in smaller cities and rural communities (without compromising quality)Dr. Penzias also shares updates on longtime Boston IVF leaders, including the evolving roles of Drs. Michael Alper and Selwyn Oskowitz, and reflects on how mentorship and tradition continue to drive innovation.This episode is a thoughtful look at legacy, leadership, and how fertility care evolves without losing its soul.

Event Objectives:Identify Key Strategies for Physician Leadership During Major Transitions in Health Care.Evaluate the Impact of National and Local Policy Priorities on Pediatric Surgical Practice.Apply Advocacy and Innovation to Advance Equitable Pediatric Health Outcomes.Claim CME Credit Here!

Imaging With Intention: Optimizing Care Through Collaboration in Diagnostic Radiology Link for CME Credit: https://cmetracker.net/UTHSCSA/Publisher?page=pubOpen#/getCertificate/10101474 Host and Executive Producer Holly Wayment and UT Health San Antonio's Department of Pediatrics bring us this  Grand Rounds episode with Desi Schiess, MD,  pediatric radiologist. This episode reviews evidence-based imaging choices, radiation considerations, and practical tips for ordering X‑ray, ultrasound, CT, MRI, fluoroscopy, and nuclear medicine in children. It includes case examples, a quiz, and guidance on when to consult a radiologist to ensure safe, effective pediatric imaging.

Both corticosteroid injection and PRP demonstrate initial efficacy where steroid appears to provide superior pain relief, as you can see here going down within the first four weeks, whereas PRP demonstrated longer lasting effect, as you can see that the VAS score is actually going down all the way up to 24 weeks, where the corticosteroid injections kind of peak at four weeks, and then slowly the pain comes back to its original level by 24 weeks, maybe around, even like a 12 weeks' time mark. So, both steroid and PRP are considered safe and an effective treatment for the GTPS. But in more recently years, it seems like PRP has a better efficacious indication over CSI for the treatment of GTPS. In a recent system review, it was concluded that PRP seems to be safe and effective when treating degenerative meniscus tears. However, additional studies are warranted. It seems like I'm going to sound like a broken record here, but truly understanding clinical implications of PRP on meniscus treatment due to heterogeneity of the studies reviewed. Similarly, in a recent review, although PRP appears to yield improvements in clinical outcomes. its clinical significance remains uncertain given, again, heterogeneity of the studies. Regarding knee ligament injuries, injection treatment is typically not common for knee ligament related injuries, but injection therapies have a role in reflective cases or when there are significant functional limitations due to pain. Introduction by Dr. Francis Lopez.  Q&A followed Part 2. 

Event Objectives:Review the history of patient safety and quality improvement in healthcare since 1999Describe the national landscape on transformationDiscuss a new way of thinking about transformationClaim CME Credit Here!

Event Objectives:Reframe pediatric MRI as a patient-centered, efficient diagnostic tool by understanding how abbreviated, non-contrast, and sedation-free protocols can safely answer many common clinical questions.Recognize when “less imaging” can be more effective, including situations where targeted MRI protocols provide sufficient diagnostic information while reducing burden, cost, and risk to children and families.Appreciate the system-level changes required, including workflow, staffing, radiologist practice, vendor collaboration, and billing, to enable the next generation of pediatric MRI.Claim CME Credit Here!

Sex Differences in Asthma: What Genomics Can Teach Us

Dr. Haruki Ishii discussed a review paper on the risks and benefits of corticosteroid injections versus plasma injections in patients. The aim of this review was to compare the evidence for clinical applications of these injectates as a treatment for a variety of musculoskeletal conditions in patients. Platelet-Rich Plasma (PRP) injections for clinical use as discussed here, is defined as autologous  plasma, extracted from minimally processed blood, and then containing activated platelets. So PRP delivers concentrated growth factors and cytokines acting as extra cell signaling molecules at the side of the injection. Key clinical applications of PRP include tendinopathies, osteoarthritis, muscle injuries, and then post -surgical healing treatment. The first study looked at is one published in 2021, a systemic review article. What it showed was that the corticosteroid injection yielded significant superior functional recovery and in pain compared with the PRP injections for rotator cuff lesions during the short -term follow-up period. He referred to an article that looked at the difference between a corticosteroid injection and a PRP injection for frozen shoulder patients, involving the functional outcome between those two injectates. Introduction by Dr. Francis Lopez. 

Event ObjectivesReview the history of Medicaid.Understand the importance of Medicaid to adolescents and young adults with special health care needs (AYASHCN).Describe anticipated impacts for Medicaid funding on AYASHCN and the health care transition.Claim CME Credit Here!

The modes and methods of medical education have changed drastically in the past decade. Social media, podcasts (like this one), and other on-demand learning formats have fundamentally shifted how healthcare professionals stay up to date and advance their practice. So what's next? Dr. Rusty Hofmann, former chief of interventional radiology at Stanford, current Chief of Industry Partnerships for Stanford Healthcare, and Medical Director of Cardiac and Interventional Services at Stanford, joins host Dr. Aaron Fritts to discuss how he's redefining the future of personalized learning. --- SYNPOSIS Dr. Hofmann shares an update on his company, Grand Rounds—now called Included Health—a personalized healthcare platform delivering virtual primary and specialty care to millions of Americans. Dr. Hofmann reflects on the journey behind Included Health and introduces his latest venture, Wysdom, a next-generation learning platform reimagining medical education through short, TikTok-style videos created by clinicians, for clinicians. He dives into the innovation of building a peer-reviewed, clinician-driven video library centered on real-world clinical cases. He discusses both the challenges and transformative potential of technology in medical education, spanning learners from trainees to seasoned clinicians. The episode concludes with his perspective on what's next—and where the company is ultimately headed. --- TIMESTAMPS 00:00 - Introduction03:23 - Grand Rounds and Included Health05:29 - Challenges in Healthcare and Entrepreneurship12:28 - The Evolution of Medical Education16:37 - Creating and Sharing Medical Content20:52 - Curation and Organization of Medical Content27:41 - Morning Rounds: A Social Media Platform for Healthcare Professionals30:08 - Educational Content and Industry Collaboration35:08 - Creating Engaging and Practical Medical Videos40:55 - The Future of Medical Education48:18 - Final Thoughts and Reflections --- RESOURCES VI Episode 100https://www.backtable.com/shows/vi/podcasts/100/why-dr-rusty-hofmann-built-an-innovative-digital-health-company Wysdom Websitehttps://www.medicalwysdom.ai/home

Event Objectives:Analyze the clinical rationale for fetal repair of gastroschisis by distinguishing between simple and complex presentations and applying evidence-based selection criteria.Evaluate the translational evidence from animal models that informed the trial design and regulatory approval for fetal gastroschisis repair.Assess early clinical outcomes from the trial to determine implications for current fetal surgery practice and future directions in therapy.Claim CME Credit Here!

Dr. Douglas Kupas joins Rob Lawrence to kick off EMS One-Stop in 2026, reflecting on his first year as President of NAEMSP — a year he describes as fast-moving, complex and occasionally “whack-a-mole,” with emerging issues demanding real-time leadership while long-term priorities still had to move forward. He shares what he's learned about the presidency, the value of NAEMSP's leadership “bench strength,” and why advocacy and coalition-building across national EMS organizations has become more coordinated, more strategic and more essential. The conversation then turns to what's immediately ahead: the NAEMSP Annual Meeting in Tampa (late January), including pre-conference courses, the flagship Medical Director's Course, and a packed scientific program. Kupas highlights a keynote focused on transforming battlefield trauma care; major research programming through oral abstracts and hundreds of posters; and high-impact sessions spanning clinical care, operations, legal issues, and international perspectives — reinforcing why the Tampa meeting remains a must-attend event for anyone serious about the science and future of EMS. Episode timeline 00:00 – Rob tees up NAEMSP Annual Meeting growth as a “good problem to have” 00:50 – Welcome/Happy New Year 2026; Dr. Kupas introduced as first guest of the year 01:45 – Year one as NAEMSP president: what's surprised Dr. Kupas, pace of work, governance “bench strength” 04:26 – NEMSAC termination: what happened, what NAEMSP hopes comes next 07:02 – Building the pipeline: medical student/resident interest group, travel support ideas 08:47 – “Hot off the press:” NAEMSP accepted into WHO Acute Care Action Network 10:08 – Advocacy “hunting as a pack:” overlapping national orgs, EMS on the Hill coordination 12:40 – Why Hill visits work: stories, staffers and why first-timers matter 16:48 – “White hat” advocacy and patient-centered priorities; ED wall time as a key issue 20:07 – Tampa preview: “It's not just for docs,” NAEMSP membership structure 22:11 – Pre-cons overview: Medical Director's Course, QI workshop, MIH, ventilation, blood, TECC 23:55 – Keynote: Dr. Frank Butler and special intro by Dr. Bob Mabry; Grand Rounds obstetric focus 27:45 – Major legal session format and why legal content draws a crowd 29:28 – Space constraints and future planning: small convention centers; San Diego “buyout” scale 31:49 – Research explosion: oral abstracts, posters, receptions; better ways to access abstracts 34:39 – “Meat of the conference:” operations, clinical topics, international speakers/learning 36:49 – Closing question: Bill details Enjoying the show? Email editor@ems1.com to share feedback or suggest guests for a future episode. 

Welcome to the Center for Medical Simulation's Grand Rounds presentation of the new publication in Advances in Simulation, “The Advocacy Inquiry Rubric (AIR), a Standard to Build Debriefing and Feedback Skills”. Lead author Clément Buléon, an anesthesiologist based in Caen, France, joins CMS Senior Director of Innovation Jenny Rudolph and CMS Assistant Director of Instructional Design James Lipshaw, both co-authors on the paper, to discuss how the AIR can be used to give effective, efficient feedback on questions in debriefing and feedback conversations. Our belief is that this tool can be used like the DASH to help educators improve their own performance in learning conversations, as well as the performance of others. In addition to discussing the structure and use of the AIR, James presents a series of debriefer videos to Clement and Jenny, who then have to use the AIR to provide feedback to the debriefer. We hope to model how you can “see through the eyes of the AIR” to provide effective, standards-based feedback for educators. Watch the Grand Rounds here: Or listen on Apple Podcasts: https://podcasts.apple.com/us/podcast/the-center-for-medical-simulation/id1279266822 #debriefing #healthcaresimulation #medicine #nursing

Dr. Kathleen Martin Ginis is a Distinguished University Scholar and a Professor in the Department of Medicine (Division of Physical Medicine and Rehabilitation) and in the School of Health and Exercise Sciences at The University of British Columbia. She holds the Reichwald Family Chair in Preventive Medicine and is a Fellow of the Royal Society of Canada, the Canadian Academy of Health Sciences, the Canadian Society for Psychomotor Learning and Sport Psychology, and as is an International Fellow of the National Academy of Kinesiology. The focus of Dr. Martin Ginis's research is placed on understanding and changing physical activity behaviour, particularly among people living with spinal cord injury. She is deeply committed to knowledge translation; specifically, the development and implementation of evidence-based best-practices to improve health and well-being among people with disabilities. By example, Dr. Martin Ginis spearheaded the formulation and knowledge translation of scientific exercise guidelines for adults with spinal cord injury. These guidelines have been translated into nearly 20 languages and are used worldwide in clinical and community settings. Part 2 Eighty percent admittedly is an arbitrary number, but it's one that most exercise scientists use as a sort of the minimum threshold for deeming someone adherent to the protocol. There were no differences in pain reduction between those with neuropathic versus musculoskeletal pain, but the small ends, small sample sizes for those two groups, make it difficult to really confirm that there is no difference in exercise outcomes for those two groups. She thinks we need to look at that further with bigger samples for each type of pain. Given the pragmatic nature of the trial that we let people exercise on their own in the community, she thinks this speaks to the feasibility of using exercise as a pain self-management strategy, but with the caveat that it's likely not going to be effective for everyone. Fifty percent of people with spinal cord injury report no leisure time physical activity whatsoever. In other words, no activity that could potentially improve cardiorespiratory fitness or muscle strength. And that's not the fault of people with spinal cord injury. Factors that influence physical activity don't just rest within the person, but they rest within society.

Event Objectives:Understand why Medicaid matters for Connecticut Children's, our patients and their familiesLearn about Connecticut Children's partners in Medicaid advocacyDiscuss how Medicaid policy changes are likely to impact children and families in 2026Claim CME Credit Here!

Dr. Kathleen Martin Ginis is a Distinguished University Scholar and a Professor in the Department of Medicine (Division of Physical Medicine and Rehabilitation) and in the School of Health and Exercise Sciences at The University of British Columbia. She holds the Reichwald Family Chair in Preventive Medicine and is a Fellow of the Royal Society of Canada, the Canadian Academy of Health Sciences, the Canadian Society for Psychomotor Learning and Sport Psychology, and as is an International Fellow of the National Academy of Kinesiology. The focus of Dr. Martin Ginis's research is placed on understanding and changing physical activity behaviour, particularly among people living with spinal cord injury. She is deeply committed to knowledge translation; specifically, the development and implementation of evidence-based best-practices to improve health and well-being among people with disabilities. By example, Dr. Martin Ginis spearheaded the formulation and knowledge translation of scientific exercise guidelines for adults with spinal cord injury. These guidelines have been translated into nearly 20 languages and are used worldwide in clinical and community settings. Part 1 One of her objectives is to present recent data showing the physical and mental health benefits of exercise for adults with spinal cord injury. She wants to introduce exercise guidelines for adults with SCI. Starting with the benefits of exercise from a mental and physical health perspective, probably the best two areas, best two outcomes for which there is evidence are improving insulin sensitivity and cardiovascular disease risk in this population. The fitness guideline stipulates that to improve cardiorespiratory fitness and muscle strength, adults with SCI should do at least 20 minutes of moderate to vigorous intensity, aerobic activity twice per week, and strength training exercises twice per week. The guideline for cardiometabolic health stipulates that a minimum of 30 minutes of moderate to vigorous intensity physical activity is required three times per week. She discussed how exercise improves well-being. She also talked about exercise in chronic pain. She described the Epic SCI trial, a pragmatic, randomized controlled trial, testing the effects of exercising according to the scientific SCI exercise guidelines on SCI chronic pain.

Event Objectives:Identify updated vocabulary for burn classification.Identify appropriate initial dressings for acute burn injury.Understand complications of burn injury and their prevention.Claim CME Credit Here!

Event Objectives:History of VUR ManagementMaking sense of the dataEstablish a management philosophy that prioritizes renal risk from an individual and population based perspectiveClaim CME Credit Here!

Event Objectives:Discuss historical risk factors associated with fetal fentanyl syndrome.Review physical exam findings associated with Fetal Fentanyl Syndrome.Discuss transient abnormalities in 7 and 8-dehydrocholesterol associated with fetal fentanyl syndrome.Claim CME Credit Here!

Can your cholesterol drop more than 150 points in just 15 days without medication?   Dr. Ted Barnett joins Chuck Carroll at the International Conference on Nutrition and Medicine to reveal the stunning results he's seeing with patients who adopt a whole food plant-based diet.   Inside Lifestyle Medicine Grand Rounds, Dr. Barnett has witnessed cholesterol levels fall by 150–200 points in two weeks, average drops of 64 points, and dramatic improvements in blood sugar, inflammation, and energy — often outperforming the results of statins.   This episode dives deep into why lifestyle changes can be more powerful than prescriptions, what's holding back the medical system from using these tools, and how simple foods like arugula, broccoli, sweet potatoes, mushrooms, and black-eyed peas can transform your health quickly.   What You'll Learn:  - How patients are lowering cholesterol 150+ points naturally - Why whole food plant-based diets outperform many medications - The 15-Day Jumpstart program and its life-changing results - Why the medical system overlooks lifestyle solutions - The top foods Dr. Barnett "prescribes" to every patient - How doctors collaborate in Lifestyle Medicine Grand Rounds - How you can experience similar results at home   Please support PCRM and The Exam Room Podcast on Giving Tuesday. Your gift will be matched dollar-for-dollar to fuel the content you love, like this podcast, while keeping all of PCRM's lifesaving work moving full steam ahead. Please donate today: https://pcrm.org/examroommatch  

In this final chapter of the 2025 season of Always on EM, Alex and Venk are thrilled to share an amazing Grand Rounds recording from the esteemed educator and clinician, Dr. Neha Raukar. She is renowned for her expertise in many areas - among them, concussion and traumatic brain injury, particularly of athletes. She breaks down imaging guidelines, evaluation of TBI, prognosis, counseling of patients and more in this fantastic talk essential for any emergency healthcare professional to hear!   CONTACTS X - @AlwaysOnEM; @VenkBellamkonda; @NehaRaukarMD YouTube - @AlwaysOnEM; @VenkBellamkonda Instagram – @AlwaysOnEM; @Venk_like_vancomycin; @ASFinch; @NehaRaukarMD Email - AlwaysOnEM@gmail.com   WANT TO WORK AT MAYO? EM Physicians: https://jobs.mayoclinic.org/emergencymedicine EM NP PAs: https://jobs.mayoclinic.org/em-nppa-jobs   Nursing/Techs/PAC: https://jobs.mayoclinic.org/Nursing-Emergency-Medicine EMTs/Paramedics: https://jobs.mayoclinic.org/ambulanceservice All groups above combined into one link: https://jobs.mayoclinic.org/EM-Jobs  

Event Objectives:Increase knowledge and awareness of spinal deformities other than idiopathic scoliosis.Discuss evaluation and treatment of spine disorders in the outpatient setting.Identify when to refer spine patients to spine specialists.Claim CME Credit Here!

Allergen- and Damage-sensing Epithelial Cells in the Airways

Event Objectives:List perinatal conditions that lead to brain injury.List neuroprotective therapies shown to protect the brain in term infant and harm the brain in preterm infants.Understand that different therapies may benefit one sex and harm the other sex.Claim CME Credit Here!

Event Objectives:Identify options for Chiari malformation surgery, craniofacial surgery and epilepsy surgery in children that optimize outcomes while providing less invasive alternatives.Claim CME Credit Here!

Event Objectives:Identify at least two stigmatizing words and alternatives.Discuss the correlation between mental health and substance abuse.Claim CME Credit Here!

On Friday, Oct. 17, the Physician Enterprise hosted a Grand Rounds session discussing evidence-based updates for respiratory immunization clinical guidelines. We also have this additional resource available related to fall viruses and immunizations:5-Minute Check In: Fall Viruses and Vaccinationshttps://youtu.be/PowPADYqzGA?si=x_G3XJY_335rcdW2

Despite that body mass index (BMI) is a measure widely recognized as imprecise and of limited diagnostic utility, it remains in use in health care, including in procedure candidacy screening and to disqualify some patients' access to indicated interventions. In this Sept 10th Grand Rounds, Drs Fatima Cody Stanford and Natalie Boero will examine the clinical applications of BMI and their effects on patients, and how our understanding of the obesity "epidemic" has evolved. Recorded September 10, 2025.  Watch the video and claim CE credit at JournalOfEthics.org

Event Objectives:Become familiar with the bullous eruption of atypical hand, foot, mouth disease.Understand the concept of a bat bite.Clarify that "Chronic Lyme disease" defined as, persistent infection despite antibiotic therapy, has never been scientifically shown.Claim CME Credit Here!

Link for CME Credit: https://cmetracker.net/UTHSCSA/Publisher?page=pubOpen#/getCertificate/10101120   Host Holly Wayment and the Department of Pediatrics bring us a recent grand rounds talk by Dr. Mario Fierro where he reviews how autism is defined under DSM‑5, explains core diagnostic areas (social/communication deficits and restricted/repetitive behaviors), and emphasizes age‑based interpretation and the spectrum of severity. He covers screening (M‑CHAT), standardized assessments (ADOS, CARS), common comorbidities and risk factors (genetics, prematurity, congenital conditions), and practical considerations for clinicians and families. He also discusses treatment options—speech/OT, ABA, FDA‑approved medications for symptoms—reviews alternative therapies and controversies (including leucovorin research and vaccine myths), and offers pragmatic advice on when to refer and focus on functional communication.

Event Objectives:Review the evolution of training tools and a partner-driven team-based outpatient approach to CBT for pediatric anxiety.Discuss how team-based models can expand the mental health workforce and improve access to quality care.Identify strategies to accelerate and scale innovative training and workforce development solutions to address the youth anxiety crisis.Claim CME Credit Here!

Drs. Ruby Patel and Rajdeep Pooni present Grand Rounds using a 12-year-old case to illustrate pediatric systemic lupus erythematosus and class IV lupus nephritis, covering presentation, biopsy findings, and pathology. The talk explains diagnostic criteria and typical lab features. They summarize current management including 2024 ACR guidance on induction therapies (steroids, mycophenolate, cyclophosphamide, and biologics), monitoring for complications and medication side effects, vaccination precautions for immunocompromised patients, and the pediatrician's role in long-term coordination of care.

Event Objectives:Identify common referrals in pediatric rheumatology and utilize resources available for guidance.Apply evidence-based approach to the initial evaluation of patients presenting with musculoskeletal complaints.Differentiate clinical features suggestive of inflammatory versus non-inflammatory etiology of symptoms in patients presenting with musculoskeletal complaints.Claim CME Credit Here!

A conversation with Dr. Steve Gittleman on predicting, preventing, and treating type 1 diabetes—covering genetics, environmental triggers, screening, and emerging therapies like teplizumab to delay or alter disease progression. Free Juicebox Community (non Facebook) Type 1 Diabetes Pro Tips - THE PODCAST Eversense CGM Medtronic Diabetes Tandem Mobi ** twiist AID System Drink AG1.com/Juicebox Use code JUICEBOX to save 40% at Cozy Earth  CONTOUR NextGen smart meter and CONTOUR DIABETES app Dexcom G7 Go tubeless with Omnipod 5 or Omnipod DASH * Get your supplies from US MED  or call 888-721-1514 Touched By Type 1 Take the T1DExchange survey Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! *The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.  ** t:slim X2 or Tandem Mobi w/ Control-IQ+ technology (7.9 or newer). RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older. BOXED WARNING:Control-IQ+ technology should not be used by people under age 2, or who use less than 5 units of insulin/day, or who weigh less than 20 lbs. Safety info: tandemdiabetes.com/safetyinfo Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!  

In this chapter of Always on EM, Dr. Lacey Shiue, Associate Director of Emergency Ultrasound for Mayo Clinic Emergency Medicine in Rochester, challenges us to recognize the morbidity and mortality associated with rib fractures and to rethink the way we consider pain management for people suffering these injuries.   CONTACTS X - @AlwaysOnEM; @VenkBellamkonda YouTube - @AlwaysOnEM; @VenkBellamkonda Instagram – @AlwaysOnEM; @Venk_like_vancomycin; @ASFinch; @Lacey.Shiue Email - AlwaysOnEM@gmail.com  

Event Objectives:Define at least five key terms related to brain injury, including acquired brain injury (ABI) and traumatic brain injury (TBI).List at least three common causes of ABI and TBI.Distinguish at least four key differences between pediatric and adult brain injury.Claim CME Credit Here!

Send us a textOn this episode, we discuss items learned at the Civil Aviation Medical Association meeting (CAMA) in Spokane, Washington along with a few updates from the FAA communicated on the recent AME Grand Rounds held virtually this past week.

Is this the U.K.'s moment to capitalize on its biotech ecosystem? That was one of the primary themes discussed at the debut Grand Rounds — Europe conference last week in Cambridge, U.K. BioMarin's James Sabry and Astex's Michelle Jones joined BioCentury's analysts on a special edition of the BioCentury This Week podcast recorded live at the event to discuss their key takeaways from the two-day conference.Beyond the state of the U.K. biopharma ecosystem, the analysts discussed the meeting's major science themes, including what's next for DNA damage repair pathway targets, both inside and outside of cancer; whether obesity should be recast as a brain disease; and the cutting edge of small molecule design.View full story: https://www.biocentury.com/article/657082#UKBiotech #TranslationalMedicine #DrugPricing #GlobalCollaboration #Aging #Biologics #SmallMolecules #Biobanking00:00 - Introduction00:35 - Key Takeaways02:14 - The State of the U.K. Biotech Ecosystem09:01 - Scientific Highlights & Panel Takeaways22:44 - Closing Remarks and Future EventsTo submit a question to BioCentury's editors, email the BioCentury This Week team at podcasts@biocentury.com.Reach us by sending a text

Event Objectives:Identify at least two systemic factors contributing to poor health outcomes in youth with sickle cell disease.Explain the impact of provider bias on health outcomes in pediatric sickle cell disease.Describe two bias-mitigating strategies that can be used by health care providers.Claim CME Credit Here!

Pediatric endocrinologist Dr. Michael Haller explores inhaled insulin and the evolving approval process for children under 18. Free Juicebox Community (non Facebook) Type 1 Diabetes Pro Tips - THE PODCAST Eversense CGM Medtronic Diabetes Tandem Mobi ** twiist AID System Drink AG1.com/Juicebox Use code JUICEBOX to save 40% at Cozy Earth  CONTOUR NextGen smart meter and CONTOUR DIABETES app Dexcom G7 Go tubeless with Omnipod 5 or Omnipod DASH * Get your supplies from US MED  or call 888-721-1514 Touched By Type 1 Take the T1DExchange survey Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! *The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.  ** t:slim X2 or Tandem Mobi w/ Control-IQ+ technology (7.9 or newer). RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older. BOXED WARNING:Control-IQ+ technology should not be used by people under age 2, or who use less than 5 units of insulin/day, or who weigh less than 20 lbs. Safety info: tandemdiabetes.com/safetyinfo Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!

Dr. Alessi welcomes Dr. Cory Edgar, associate professor of orthopedic surgery and co-director of the Institute of Sports Medicine at the University of Connecticut, to discuss throwing, stem cells, and biologics in orthopedic surgery, examining what actually works and what doesn't. He also reflects on the recent rise in West Nile virus cases, exploring possible causes and strategies for prevention. Additionally, Dr. Alessi shares insights from his visit to Grand Rounds at Hartford Hospital and highlights an interesting article he read this week on the connection between credit scores and mental health.

Novel Imaging Techniques and Phenotypes in Asthma and COPD

MD Anderson fellows discuss AML, MRD endpoints, and evolving trial strategies in a dynamic grand rounds–style presentation.

Dr. Ronald (James) Cotton who is an electrical engineer, neuroscientist, and physiatrist working as a physician scientist at Shirley Ryan Ability Lab, and assistant professor in the Northwestern University Department of Physical Medicine and Rehabilitation. We have this one paper where we can use diffusion models and generate a bunch of probabilistic samples of movements and they constrain them by what we see in the cameras and have shown that we can actually estimate the confidence and the uncertainty in a reliable way. He indicated that we can use something called the myoskeleton that allows us to track all joints in the body down to the individual fingers. Our Portable Biomechanics Laboratory is kind of a combination of a smartphone app that records the rotation and movement of the phone itself. He discussed how he would like to establish validity as a predictive biomarker. He asked what do we actually want and what do we mean by precision rehabilitation? In his mind, the best formalism of it is something called the optimal dynamic treatment regime, which essentially is some kind of function, probably a learned function that looks at all the health information, all the biomarkersof an individual at any point in rehabilitation, kind of condenses that into a phenotype, and then predicts what is the next intervention that should be given. He spoke briefly about a case studythat applies to another line of research in his lab, which is EMG-based biofeedback and also about Next Generation Brain Machine Interface Chips.

Dominate C. diff! Learn to distinguish colonization from infection, select first-line therapies, and counsel patients on recurrence prevention and microbiome recovery. We're joined by IDSA past president and expert on foodborne and intestinal infections, Dr. Cindy Sears (Johns Hopkins University) for a comprehensive update on Clostridioides difficile (C. diff, Cdiff, CDAD, CDI). Claim CME for this episode at curbsiders.vcuhealth.org! Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Show Segments 00:00 Intro 03:00 Guest bio and hobby 04:25 Case of Charles Fleur Fontaine 06:00 Risk factors and epidemiology 08:00 Antibiotic hierarchy of risk 10:00 Diagnosis, testing strategies 14:00 Defining severity 17:30 Treatment options 20:00 Microbiome recovery strategies 24:00 Probiotics and postbiotics 27:00 Infection control counseling 30:00 C. diff and colon cancer 32:00 Recurrent C. diff strategies 35:00 Why some FMT and bezlotoxumab were discontinued 38:00 Microbiota replacement therapies 43:00 Prophylaxis strategies 45:00 Future therapies and ongoing research 47:00 Audience Q&A 52:00 Outro Credits Written and Produced by: Matthew Watto, MD, FACP  Cover Art and Infographic by: Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP    Reviewer: Sai S Achi MD,MBA,FACP Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Guest: Cynthia Sears MD Disclosures Dr. Sears reports no relevant financial disclosures. Dr. Williams financial relationships disclosed include a Merck grant or research support. This relationship has not ended. Sponsor: Mint Mobile  This year, skip breaking a sweat AND breaking the bank. Get this new customer offer and your 3-month Unlimited wireless plan for just 15 bucks a month at mintmobile.com/CURB  Sponsor: Panacea Financial Let Panacea Financial take the financial stress off your plate,so you can get back to doing what matters most. Visit panaceafinancial.com  Sponsor: FIGS Get15% off your first order at wearfigs.com with the code FIGSRX

Dr. Ronald (James) Cotton who is an electrical engineer, neuroscientist, and physiatrist working as a physician scientist at Shirley Ryan Ability Lab, and assistant professor in the Northwestern University Department of Physical Medicine and Rehabilitation. PART 1 All of us probably believe and understand that how someone moves and walks is hugely informative. People are exuding all this information about their health status, but we don't measure it and obviously a core treatment of rehabilitation is how people move. We don't actually routinely measure that and the reason is that we need better, more clinically accessible tools to measure the clinically meaningful things about movement and then use those to guide our treatment programs. We've never really had the tools. So, I'm going to discuss a plurality of methods we've been developing in my lab, including tools that use multi-view video, monocular video from a smartphone, for example, as well as sensor technology and then how we're trying to extract clinically meaningful metrics from these methods. A challenge we've been addressing in the lab is that the tools developed by the AI community don't necessarily solve the problems that we need or produce clinically relevant outputs. It's really important to have confidence intervals on what you measure. If we're going to use anything for decision making, we have to know we can trust it. A problem with a lot of computer vision algorithms is they don't provide anything like confidence intervals. Even if they pretend to, they're often uncalibrated and unreliable.

The FiltrateJoel Topf Bluesky: @kidneyboy.bsky.social‬Jordy Cohen Bluesky: @jordybc.bsky.social‬Swapnil Hiremath Bluesky: @hswapnil.medsky.social‬Special Guest Edouard “call me Ed” Fu Assistant Professor and Medical Student, and second author of his second paper covered on NephJC. LinkedIn | Leiden University Medical CenterEditing bySimon Topf and Sophia AmbrusoThe Kidney Connection written and performed by by Tim YauShow NotesEd's first paper on NephJC: Timing of dialysis initiation to reduce mortality and cardiovascular events in advanced chronic kidney disease: nationwide cohort study (NephJC | BMJ)Phenformin Wikipedia | Boca Raton NewsThe metformin black box (as part of the FDA Label)WARNING: LACTIC ACIDOSISPostmarketing cases of metformin-associated lactic acidosis have resulted in death, hypothermia, hypotension, and resistant bradyarrhythmias. The onset of metforminassociated lactic acidosis is often subtle, accompanied only by nonspecific symptoms such as malaise, myalgias, respiratory distress, somnolence, and abdominal pain. Metforminassociated lactic acidosis was characterized by elevated blood lactate levels (>5 mmol/Liter), anion gap acidosis (without evidence of ketonuria or ketonemia), an increased lactate/pyruvate ratio; and metformin plasma levels generally >5 mcg/mL (see PRECAUTIONS).Risk factors for metformin-associated lactic acidosis include renal impairment, concomitant use of certain drugs (e.g. carbonic anhydrase inhibitors such as topiramate), age 65 years old or greater, having a radiological study with contrast, surgery and other procedures, hypoxic states (e.g., acute congestive heart failure), excessive alcohol intake, and hepatic impairment.Steps to reduce the risk of and manage metformin-associated lactic acidosis in these high risk groups are provided (see DOSAGE AND ADMINISTRATION, CONTRAINDICATIONS, and PRECAUTIONS).If metformin-associated lactic acidosis is suspected, immediately discontinue metformin and institute general supportive measures in a hospital setting. Prompt hemodialysis is recommended (see PRECAUTIONS).Target Trial Emulation A Framework for Causal Inference From Observational Data. Miguel A. Hernán, MD, DrPH; Wei Wang, PhD; David E. Leaf, MD JAMA 2022Stopping Versus Continuing Metformin in Patients With Advanced CKD: A Nationwide Scottish Target Trial Emulation Study (NephJC | PubMed)Toxicokinetics of Metformin During Hemodialysis (KI Reports)Metformin in People With Diabetes and Advanced CKD: Should We Dare? Editorial that ran in AJKD along side the Lambourg manuscript (AJKD)Immortal Time Bias in Cohort Studies of Kidney Transplant Recipients (Kim SJ Amer J Trans 2010)Ed's Target trial review in JASN which Jordy mentioned and includes an explanation of the obesity paradox by depletion of the susceptibles. (Fu JASN 2023)Ed's Grand Rounds at Ottawa on YouTube. Very good.Response by Cohen et al to Letter Regarding Article, “Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19” by Jordy and the crew Circ Res 2000Review article on the issue: Evaluating sources of bias in observational studies of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker use during COVID-19: beyond confounding Jordy and a different crew J Hyperten 2021Figure S5: Weighted cumulative incidence curves for MACE, by treatment strategyThe S4 image that Swap lovedTubular SecretionsJordy Andor Season 2 on Disney+ (Wikipedia)Swapnil Murderbot on Apple TV+ (Wikipedia)Eduoard: New house and grant Grant Grant (Wikipedia)Joel Topf Three Body Problem Audio book (Audible)

Grand Rounds heads to Europe: first meeting Sept. 17 in Cambridge, U.K.There are many reasons why it may be the European biomedical ecosystem's moment to shine, and advances at the academia-industry interface are a core part of that story, particularly in Cambridge, U.K. — the site of the inaugural BioCentury Grand Rounds – Europe conference.On a special edition of the BioCentury This Week podcast, BioCentury's analysts are joined by four leaders in the Cambridge, U.K., life sciences community to preview the Sept. 17-19 meeting: Kathryn Chapman, executive director of Innovate Cambridge; Anne Horgan, partner, Cambridge Innovation Capital (CIC); Sally Mardikian, business development director, Astrazeneca plc (LSE:AZN; NASDAQ:AZN); and Kristin-Anne Rutter, executive director of Cambridge University Health Partners (CUHP).The BioCentury team and its Cambridge counterparts discuss the conference's themes and how they relate to the region's strengths, and offer both some tough love and a warm invitation to early-stage innovators looking for science-forward investors and partners.View full story: https://www.biocentury.com/article/656373#biotech #biopharma #pharma #lifescience #Discovery #Translation #BioCenturyGrandRoundsEuropeReach us by sending a text